What is GluteoStop® ?
Content and Instructions for Use
Ingredients list: Prolyl oligopeptidase 85.7%, bulking agents: Microcrystalline cellulose, cross-linked sodium carboxymethyl cellulose; anti-caking agents: Silicon dioxide, calcium salts of fatty acids.
Recommended dosage: Take 1-2 mini tablets as needed, just before a meal.
Warnings: Dietary supplements are not a substitute for a varied and balanced diet and a healthy lifestyle. Keep out of reach of small children.
Available pack sizes: 90 mini tablets = 6.3g
Storage recommendations: Please store in a dry place below 25°C.
German Quality
GluteoStop® is produced with the latest technology in our certified production facility in Germany and is subjected to rigorous testing and regular inspections to ensure that our customers are using a food supplement of the highest quality, bearing the "Made in Germany" label.
Product testing is carried out in independent accredited laboratories to ensure that GluteoStop® meets all legal requirements and complies with our own high quality standards.
Ineo Pharma®
Ineo Pharma®, based in Willich, Germany, is an international company specializing in the development, production, and distribution of high-quality dietary supplements. Its products are targeted at both the European market and international trade. By prioritizing scientifically sound formulations, exceptionally high-quality raw materials, and the European Union's regulatory requirements for dietary supplements, the company guarantees the highest quality and safety for its customers. Innovoss® is the sole authorized representative of Ineo Pharma® in Türkiye.
Scientific Articles
- Randomized clinical trial: Effective gluten degradation by Aspergillus niger -derived enzyme in a complex meal setting
- Randomized clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers
- Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study
- Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease
- Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease
- Influence of dietary components on Aspergillus niger prolyl endoprotease mediated gluten degradation
- Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements
- Determination of gluten consumption in celiac disease patients on a gluten-free diet
- Diet adherence and gluten exposure in coeliac disease and self-reported non-coeliac gluten sensitivity
- Adverse Effects of Wheat Gluten
- Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study
- Degradation of gluten in rye sourdough products by means of a proline-specific peptidase
